David Wishart’s The Metabolomics Innovation Centre helped determine how COVID-19 affects different metabolites in an effort to build new tests and possibly create secondary therapeutics. (Photo: John Ulan)

Study identifies biomarkers that could be used in a quick, inexpensive COVID-19 blood screening tool

Posted on

How COVID-19 affects concentration of certain metabolites could also pinpoint who is most at-risk of death and even lead to a secondary therapy that could improve disease outcomes.

The concentration of specific metabolites in the blood could act as the foundation for a quick, inexpensive blood test that detects not only the presence of COVID-19 but which patients are at risk of becoming critically ill, according to a pan-Canadian study that included researchers from the University of Alberta….

https://www.folio.ca/study-identifies-biomarkers-that-could-be-used-in-a-quick-inexpensive-covid-19-blood-screening-tool/

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]